Maximum-tolerated dose defined for single-agent gemcitabine: A phase I dose-escalation study in chemotherapy-naive patients with advanced non- small-cell lung cancer

F. V. Fossella, S. M. Lippman, D. M. Shin, P. Tarassoff, M. Calayag-Jung, R. Perez-Soler, J. S. Lee, W. K. Murphy, B. Glisson, E. Rivera, W. K. Hong

Research output: Contribution to journal › Article › peer-review

129 Scopus citations

Fingerprint

Dive into the research topics of 'Maximum-tolerated dose defined for single-agent gemcitabine: A phase I dose-escalation study in chemotherapy-naive patients with advanced non- small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences